LIFE SCIENCE CEO STRATEGIC GOVERNANCE FORUM

NOVEMBER 14, 2017 | SAN JOSE, CA Download AgendaRegister Now

Special Thanks to Our Supplier Partners

Executive Exchange and Dialogue for Small-to-Medium Life Science Enterprises, Fostering Mentorship, Collaboration and Driving Strategy for Sustainable Growth, High Level Corporate Management of Teams, Boards of Directors and Investors
Over the past 5 years, more than 450 Chief Executive Officers, Presidents and Founders from the life science industry have participated and engaged in the Q1 Life Science CEO Strategic Governance Forum, creating dialogue and synergy with like-minded executives rising to the challenge of a dynamic industry fueled by competitive growth, evolving regulatory and health policies and a changing population. Working with local industry leadership representing the most innovative and highly sought after organizations, Q1 has established a networking and discussion-based format which allows participants an opportunity to truly engage in the conversation, creating a problem solving and solution-based dialogue which has an immediate impact on corporate challenges.

STRATEGY SESSION DISCUSSION TOPICS FOR SELECTION:

MANAGING & LEVERAGING BOARDS OF DIRECTORS

  • Building a robust & effective board of directors
  • Defining goals and benchmarks for corporate growth
  • Management of expectations: Regulatory clearance
  • Management of expectations: Revenue generation
  • Utilization of boards in overall exit strategy execution


EXECUTIVE MANAGEMENT & LEADERSHIP DEVELOPMENT

  • Leadership excellence within the life science industry
  • Attracting & securing talented executive leadership
  • Balancing science & commercialization in executive team
  • Setting a clear mission & vision for start-up corporations
  • Corporate culture: Capturing hearts & minds

 

LOCAL LEADERSHIP CHALLENGES

  • Securing flexible office space that promotes growth
  • Leveraging the dynamic tech environment
  • Opportunities fostered by vibrant scientific community

REGULATORY & COMMERCIAL ENVIRONMENT

  • Impact of health reforms & scenario planning outcomes
  • Regulatory approval & monitoring agency expectations:
    • Pharma/Biotech | CDER/CBER
    • Medical Product | CDRH
  • International regulatory clearance & commercialization
  • Commercial frameworks: Pricing & reimbursement
  • Patient perspective on meeting unmet medical needs

SPEED NETWORKING TO FOSTER COLLABORATION:

  • Pharmaceutical / Biotechnology / Biopharmaceutical
  • Medical Device / Capital Equipment / Diagnostic
  • Digital Health Technology

GROWTH THROUGH PARTNERSHIP OPPORTUNITIES

  • Effective research & development partnerships:
    • Academic
    • Medical Centers
    • Industry
  • Commercialization partnerships to extend product reach
  • Challenges & opportunities in licensing & technology transfer
  • Global collaboration in product research & development
  • Preparing for acquisition & exit strategy management

CORPORATE FINANCE & FUNDING OPERATIONS

  • Venture capital: Opportunities, limitations & successes
  • Leverage of institutional investment for corporate funding
  • Fund raising while reducing reliance on dilutive funding
  • Preparing & positioning for initial public offerings

Contact:

Paul Hernandez | Marketing Director | Q1 Productions
312.602.9683 | [email protected]

Share This